ESPOO, Finland, March 27th, 2017 – Mobidiag Ltd, a Finnish molecular diagnostics company, today announced the opening of a new office in United Kingdom and the appointment of Stuart Cranmer as Managing Director to lead the business in one of the most strategic markets for Mobidiag. In addition to offices in Finland (headquarters), France and Sweden, Mobidiag UK will play a key role in accelerating the company’s growth locally and leveraging its global coverage.
“For the past months, we have seen a growing interest for our IVD products in UK. The UK is well known for its world-leading laboratories and hospitals, and was clearly a strategic target for developing the Mobidiag business. Our goal is to make the Amplidiag® platform and assay systems more accessible in the UK and be able to support our customers better with local support. Stuart Cranmer who will be leading the new UK office, has many years’ experience in the market and is ideally suited to help us achieve this goal” said Tuomas Tenkanen, CEO at Mobidiag.
“There has been a very positive response to the introduction of Mobidiag’s products in the UK and we are excited at the prospects going forward. The portfolio of existing and pending products has many unique characteristics that are ideally suited to the UK market and we are certain that the customer will appreciate the value they bring” said Stuart Cranmer,
Contact
Tuomas Tenkanen
+358 50553498
info@mobidiag.com
